 | • レポートコード：D005-09654 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、弱毒生ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。弱毒生ワクチンの種類別市場規模（）、用途別市場規模（病院、医療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Astellas Pharma (Japan)、Pfizer (U.S.)、GlaxoSmithKline (U.K.)、CSL Limited (Australia)、Merck & Co (U.S.)、Emergent BioSolutions (U.S.)、Serum Institute of India Pvt (India)、MedImmune (U.S.)、Johnson & Johnson (U.S.)、Sanofi Pasteur (France) ・地域別グローバル市場分析 2015年-2020年 ・弱毒生ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・弱毒生ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・弱毒生ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・弱毒生ワクチンの南米市場（ブラジル、アルゼンチン） ・弱毒生ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析： ・用途別分析：病院、医療センター、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Live Attenuated Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Live Attenuated Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Live Attenuated Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Live Attenuated Vaccine market has been segmented into
By Application, Live Attenuated Vaccine has been segmented into:
Hospital
Medical Center
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Live Attenuated Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Live Attenuated Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Live Attenuated Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Live Attenuated Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Live Attenuated Vaccine Market Share Analysis
Live Attenuated Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Live Attenuated Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Live Attenuated Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Live Attenuated Vaccine are:
Astellas Pharma (Japan)
Pfizer (U.S.)
GlaxoSmithKline (U.K.)
CSL Limited (Australia)
Merck & Co (U.S.)
Emergent BioSolutions (U.S.)
Serum Institute of India Pvt (India)
MedImmune (U.S.)
Johnson & Johnson (U.S.)
Sanofi Pasteur (France)
Among other players domestic and global, Live Attenuated Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Live Attenuated Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Live Attenuated Vaccine, with price, sales, revenue and global market share of Live Attenuated Vaccine in 2018 and 2019.
Chapter 3, the Live Attenuated Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Live Attenuated Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Live Attenuated Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Live Attenuated Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Live Attenuated Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Live Attenuated Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.3 Market Analysis by Application
1.3.1 Overview: Global Live Attenuated Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Others
1.4 Overview of Global Live Attenuated Vaccine Market
1.4.1 Global Live Attenuated Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Astellas Pharma (Japan)
2.1.1 Astellas Pharma (Japan) Details
2.1.2 Astellas Pharma (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Astellas Pharma (Japan) SWOT Analysis
2.1.4 Astellas Pharma (Japan) Product and Services
2.1.5 Astellas Pharma (Japan) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer (U.S.)
2.2.1 Pfizer (U.S.) Details
2.2.2 Pfizer (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer (U.S.) SWOT Analysis
2.2.4 Pfizer (U.S.) Product and Services
2.2.5 Pfizer (U.S.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline (U.K.)
2.3.1 GlaxoSmithKline (U.K.) Details
2.3.2 GlaxoSmithKline (U.K.) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline (U.K.) SWOT Analysis
2.3.4 GlaxoSmithKline (U.K.) Product and Services
2.3.5 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CSL Limited (Australia)
2.4.1 CSL Limited (Australia) Details
2.4.2 CSL Limited (Australia) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CSL Limited (Australia) SWOT Analysis
2.4.4 CSL Limited (Australia) Product and Services
2.4.5 CSL Limited (Australia) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck & Co (U.S.)
2.5.1 Merck & Co (U.S.) Details
2.5.2 Merck & Co (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck & Co (U.S.) SWOT Analysis
2.5.4 Merck & Co (U.S.) Product and Services
2.5.5 Merck & Co (U.S.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Emergent BioSolutions (U.S.)
2.6.1 Emergent BioSolutions (U.S.) Details
2.6.2 Emergent BioSolutions (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Emergent BioSolutions (U.S.) SWOT Analysis
2.6.4 Emergent BioSolutions (U.S.) Product and Services
2.6.5 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Serum Institute of India Pvt (India)
2.7.1 Serum Institute of India Pvt (India) Details
2.7.2 Serum Institute of India Pvt (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Serum Institute of India Pvt (India) SWOT Analysis
2.7.4 Serum Institute of India Pvt (India) Product and Services
2.7.5 Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 MedImmune (U.S.)
2.8.1 MedImmune (U.S.) Details
2.8.2 MedImmune (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 MedImmune (U.S.) SWOT Analysis
2.8.4 MedImmune (U.S.) Product and Services
2.8.5 MedImmune (U.S.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson (U.S.)
2.9.1 Johnson & Johnson (U.S.) Details
2.9.2 Johnson & Johnson (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson (U.S.) SWOT Analysis
2.9.4 Johnson & Johnson (U.S.) Product and Services
2.9.5 Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanofi Pasteur (France)
2.10.1 Sanofi Pasteur (France) Details
2.10.2 Sanofi Pasteur (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanofi Pasteur (France) SWOT Analysis
2.10.4 Sanofi Pasteur (France) Product and Services
2.10.5 Sanofi Pasteur (France) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Live Attenuated Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Live Attenuated Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Live Attenuated Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Live Attenuated Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Live Attenuated Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Live Attenuated Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Live Attenuated Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Live Attenuated Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Live Attenuated Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Live Attenuated Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Live Attenuated Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Live Attenuated Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Live Attenuated Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
6.4 France Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Live Attenuated Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Live Attenuated Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Live Attenuated Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
7.5 India Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Live Attenuated Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Live Attenuated Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Live Attenuated Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Live Attenuated Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Live Attenuated Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Live Attenuated Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Live Attenuated Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Live Attenuated Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Live Attenuated Vaccine Price by Type (2015-2020)
11 Global Live Attenuated Vaccine Market Segment by Application
11.1 Global Live Attenuated Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Live Attenuated Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Live Attenuated Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Live Attenuated Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Live Attenuated Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Live Attenuated Vaccine Market Forecast (2021-2025)
12.2.2 Europe Live Attenuated Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Live Attenuated Vaccine Market Forecast (2021-2025)
12.2.4 South America Live Attenuated Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Live Attenuated Vaccine Market Forecast (2021-2025)
12.3 Live Attenuated Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Live Attenuated Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Live Attenuated Vaccine Market Share Forecast by Type (2021-2025)
12.4 Live Attenuated Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Live Attenuated Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Live Attenuated Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Live Attenuated Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Live Attenuated Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Live Attenuated Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Astellas Pharma (Japan) Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Pharma (Japan) Live Attenuated Vaccine Major Business
Table 9. Astellas Pharma (Japan) Live Attenuated Vaccine Total Revenue (USD Million) (2018-2019)
Table 10. Astellas Pharma (Japan) SWOT Analysis
Table 11. Astellas Pharma (Japan) Live Attenuated Vaccine Product and Services
Table 12. Astellas Pharma (Japan) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pfizer (U.S.) Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer (U.S.) Live Attenuated Vaccine Major Business
Table 15. Pfizer (U.S.) Live Attenuated Vaccine Total Revenue (USD Million) (2018-2019)
Table 16. Pfizer (U.S.) SWOT Analysis
Table 17. Pfizer (U.S.) Live Attenuated Vaccine Product and Services
Table 18. Pfizer (U.S.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GlaxoSmithKline (U.K.) Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline (U.K.) Live Attenuated Vaccine Major Business
Table 21. GlaxoSmithKline (U.K.) Live Attenuated Vaccine Total Revenue (USD Million) (2018-2019)
Table 22. GlaxoSmithKline (U.K.) SWOT Analysis
Table 23. GlaxoSmithKline (U.K.) Live Attenuated Vaccine Product and Services
Table 24. GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. CSL Limited (Australia) Basic Information, Manufacturing Base and Competitors
Table 26. CSL Limited (Australia) Live Attenuated Vaccine Major Business
Table 27. CSL Limited (Australia) Live Attenuated Vaccine Total Revenue (USD Million) (2018-2019)
Table 28. CSL Limited (Australia) SWOT Analysis
Table 29. CSL Limited (Australia) Live Attenuated Vaccine Product and Services
Table 30. CSL Limited (Australia) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Merck & Co (U.S.) Basic Information, Manufacturing Base and Competitors
Table 32. Merck & Co (U.S.) Live Attenuated Vaccine Major Business
Table 33. Merck & Co (U.S.) Live Attenuated Vaccine Total Revenue (USD Million) (2018-2019)
Table 34. Merck & Co (U.S.) SWOT Analysis
Table 35. Merck & Co (U.S.) Live Attenuated Vaccine Product and Services
Table 36. Merck & Co (U.S.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Emergent BioSolutions (U.S.) Basic Information, Manufacturing Base and Competitors
Table 38. Emergent BioSolutions (U.S.) Live Attenuated Vaccine Major Business
Table 39. Emergent BioSolutions (U.S.) Live Attenuated Vaccine Total Revenue (USD Million) (2018-2019)
Table 40. Emergent BioSolutions (U.S.) SWOT Analysis
Table 41. Emergent BioSolutions (U.S.) Live Attenuated Vaccine Product and Services
Table 42. Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Serum Institute of India Pvt (India) Basic Information, Manufacturing Base and Competitors
Table 44. Serum Institute of India Pvt (India) Live Attenuated Vaccine Major Business
Table 45. Serum Institute of India Pvt (India) Live Attenuated Vaccine Total Revenue (USD Million) (2018-2019)
Table 46. Serum Institute of India Pvt (India) SWOT Analysis
Table 47. Serum Institute of India Pvt (India) Live Attenuated Vaccine Product and Services
Table 48. Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. MedImmune (U.S.) Basic Information, Manufacturing Base and Competitors
Table 50. MedImmune (U.S.) Live Attenuated Vaccine Major Business
Table 51. MedImmune (U.S.) Live Attenuated Vaccine Total Revenue (USD Million) (2018-2019)
Table 52. MedImmune (U.S.) SWOT Analysis
Table 53. MedImmune (U.S.) Live Attenuated Vaccine Product and Services
Table 54. MedImmune (U.S.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Johnson & Johnson (U.S.) Basic Information, Manufacturing Base and Competitors
Table 56. Johnson & Johnson (U.S.) Live Attenuated Vaccine Major Business
Table 57. Johnson & Johnson (U.S.) Live Attenuated Vaccine Total Revenue (USD Million) (2018-2019)
Table 58. Johnson & Johnson (U.S.) SWOT Analysis
Table 59. Johnson & Johnson (U.S.) Live Attenuated Vaccine Product and Services
Table 60. Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Sanofi Pasteur (France) Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Pasteur (France) Live Attenuated Vaccine Major Business
Table 63. Sanofi Pasteur (France) Live Attenuated Vaccine Total Revenue (USD Million) (2018-2019)
Table 64. Sanofi Pasteur (France) SWOT Analysis
Table 65. Sanofi Pasteur (France) Live Attenuated Vaccine Product and Services
Table 66. Sanofi Pasteur (France) Live Attenuated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Live Attenuated Vaccine Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Live Attenuated Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Live Attenuated Vaccine Sales by Regions (2015-2020) (K MT)
Table 70. Global Live Attenuated Vaccine Sales Market Share by Regions (2015-2020)
Table 71. Global Live Attenuated Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Live Attenuated Vaccine Sales by Countries (2015-2020) (K MT)
Table 73. North America Live Attenuated Vaccine Sales Market Share by Countries (2015-2020)
Table 74. North America Live Attenuated Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Live Attenuated Vaccine Revenue Market Share by Countries (2015-2020)
Table 76. Europe Live Attenuated Vaccine Sales by Countries (2015-2020) (K MT)
Table 77. Europe Live Attenuated Vaccine Sales Market Share by Countries (2015-2020)
Table 78. Europe Live Attenuated Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Live Attenuated Vaccine Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Live Attenuated Vaccine Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Live Attenuated Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Live Attenuated Vaccine Sales by Countries (2015-2020) (K MT)
Table 83. South America Live Attenuated Vaccine Sales Market Share by Countries (2015-2020)
Table 84. South America Live Attenuated Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Live Attenuated Vaccine Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Live Attenuated Vaccine Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Live Attenuated Vaccine Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Live Attenuated Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Live Attenuated Vaccine Revenue Market Share by Countries (2015-2020)
Table 90. Global Live Attenuated Vaccine Sales by Type (2015-2020) (K MT)
Table 91. Global Live Attenuated Vaccine Sales Share by Type (2015-2020)
Table 92. Global Live Attenuated Vaccine Revenue by Type (2015-2020) (USD Million)
Table 93. Global Live Attenuated Vaccine Revenue Share by Type (2015-2020)
Table 94. Global Live Attenuated Vaccine Sales by Application (2015-2020) (K MT)
Table 95. Global Live Attenuated Vaccine Sales Share by Application (2015-2020)
Table 96. Global Live Attenuated Vaccine Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Live Attenuated Vaccine Market Share Forecast by Regions (2021-2025)
Table 98. Global Live Attenuated Vaccine Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Live Attenuated Vaccine Market Share Forecast by Type (2021-2025)
Table 100. Global Live Attenuated Vaccine Sales Forecast by Application (2021-2025)
Table 101. Global Live Attenuated Vaccine Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Live Attenuated Vaccine Picture
Figure 2. Global Sales Market Share of Live Attenuated Vaccine by Type in 2019
Figure 3. Live Attenuated Vaccine Sales Market Share by Application in 2018
Figure 4. Hospital Picture
Figure 5. Medical Center Picture
Figure 6. Others Picture
Figure 7. Global Live Attenuated Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 8. United States Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 9. Canada Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Mexico Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Germany Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. France Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. UK Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Russia Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Italy Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. China Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Japan Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Korea Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. India Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Southeast Asia Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Australia Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 22. Brazil Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Egypt Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Saudi Arabia Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. South Africa Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Turkey Live Attenuated Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Global Live Attenuated Vaccine Sales Market Share by Manufacturer in 2019
Figure 28. Global Live Attenuated Vaccine Revenue Market Share by Manufacturer in 2019
Figure 29. Top 3 Live Attenuated Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 30. Top 6 Live Attenuated Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Key Manufacturer Market Share Trend
Figure 32. Global Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 33. Global Live Attenuated Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 34. Global Live Attenuated Vaccine Revenue Market Share by Regions (2015-2020)
Figure 35. Global Live Attenuated Vaccine Revenue Market Share by Regions in 2018
Figure 36. North America Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
Figure 37. Europe Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Asia-Pacific Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
Figure 39. South America Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Middle East & Africa Live Attenuated Vaccine Sales and Growth Rate (2015-2020)
Figure 41. North America Live Attenuated Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. North America Live Attenuated Vaccine Sales Market Share by Countries (2015-2020)
Figure 43. North America Live Attenuated Vaccine Sales Market Share by Countries in 2018
Figure 44. North America Live Attenuated Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 45. North America Live Attenuated Vaccine Revenue Market Share by Countries in 2018
Figure 46. United States Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 47. Canada Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 48. Mexico Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Europe Live Attenuated Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. Europe Live Attenuated Vaccine Revenue Market Share by Countries (2015-2020)
Figure 51. Europe Live Attenuated Vaccine Revenue Market Share by Countries in 2019
Figure 52. Germany Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 53. UK Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 54. France Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Russia Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Italy Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Asia-Pacific Live Attenuated Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Asia-Pacific Live Attenuated Vaccine Sales Market Share by Regions 2019
Figure 59. Asia-Pacific Live Attenuated Vaccine Revenue Market Share by Regions 2019
Figure 60. China Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Japan Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Korea Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 63. India Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Southeast Asia Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 65. South America Live Attenuated Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. South America Live Attenuated Vaccine Sales Market Share by Countries in 2019
Figure 67. South America Live Attenuated Vaccine Revenue Market Share by Countries in 2019
Figure 68. Brazil Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Argentina Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Middle East and Africa Live Attenuated Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. Middle East and Africa Live Attenuated Vaccine Sales Market Share by Countries in 2019
Figure 72. Middle East and Africa Live Attenuated Vaccine Revenue Market Share by Countries (2015-2020)
Figure 73. Middle East and Africa Live Attenuated Vaccine Revenue Market Share by Countries in 2019
Figure 74. Saudi Arabia Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Egypt Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Turkey Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 77. South Africa Live Attenuated Vaccine Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Global Live Attenuated Vaccine Sales and Growth Rate (2021-2025) (K MT)
Figure 79. Global Live Attenuated Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 80. North America Sales Live Attenuated Vaccine Market Forecast (2021-2025) (K MT)
Figure 81. Europe Sales Live Attenuated Vaccine Market Forecast (2021-2025) (K MT)
Figure 82. Asia-Pacific Sales Live Attenuated Vaccine Market Forecast (2021-2025) (K MT)
Figure 83. South America Sales Live Attenuated Vaccine Market Forecast (2021-2025) (K MT)
Figure 84. Middle East & Africa Sales Live Attenuated Vaccine Market Forecast (2021-2025) (K MT)
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
麻疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Measle Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Measle Vaccine market report p…- 病気管理＆予防ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Disease Control and Prevention Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 55270 million by 2025, from USD 42850 million in 2019. The…
- ライム病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyme Disease Vaccine mar…
- 日本脳炎ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Japanese Encephalitis (JE) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Japanese E…
- ヒト用予防ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Prophylactic Human Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prophylactic Human…